GitLife Biotech is a version control system for synthetic biology, alongside a suite of DNA-based biosecurity tools.
GitLife Biotech has raised $615K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
GitLife Biotech's investors include Cambridge Future Tech, Mandashi.
GitLife Biotech is headquartered in Newcastle, United Kingdom.
GitLife Biotech is a version control system for synthetic biology, alongside a suite of DNA-based biosecurity tools.
GitLife Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GitLife Biotech — Funding & Investors." VCBacked, February 27, 2023, https://www.vcbacked.co/company/gitlife-biotech. Accessed August 14, 2026.
VCBacked. (2023). GitLife Biotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/gitlife-biotech
{{cite web |title=GitLife Biotech — Funding & Investors |url=https://www.vcbacked.co/company/gitlife-biotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated